--DaVita Inc. announced financial and operating results for the quarter ended December 31, 2024. Consolidated revenues were $3.295 billion and $12.816 billion for the three months and year ended ...

Earlier this week, DaVita highlighted its Community Health Experience initiative, working with partners such as the American Diabetes Association and the YMCA to provide no‑cost screenings and ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Shares of DaVita Inc. DVA slipped 1.01% to $111.45 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.65% to 6,966.28 and the ...

In the latest trading session, DaVita HealthCare (DVA) closed at $111.01, marking a -3.23% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.34%. Meanwhile, ...

DaVita HealthCare Partners stock reached a new 52-week low, hitting $112.53. This marks a significant downturn for the company, which has experienced a 24.81% decline over the past year.